Amedica Corporation (AMDA) Shares are Down -4.43%

Amedica Corporation (AMDA) : During the past 4 weeks, traders have been relatively bearish on Amedica Corporation (AMDA), hence the stock is down -12.02% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -4.84% relative to the S&P 500. The 4-week change in the price of the stock is -9.83% and the stock has fallen -4.43% in the past 1 week.

Amedica Corporation (NASDAQ:AMDA): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $0.80 and $0.78 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $0.81. The buying momentum continued till the end and the stock did not give up its gains. It closed at $0.80, notching a gain of 0.04% for the day. The total traded volume was 440,906 . The stock had closed at $0.80 on the previous day.

The stock has recorded a 20-day Moving Average of 2.58% and the 50-Day Moving Average is 28.64%. Amedica Corporation has dropped 43.8% during the last 3-month period . Year-to-Date the stock performance stands at -55.29%.

Amedica Corporation (AMDA) : 2 investment research analysts covering Amedica Corporation (AMDA) have an average price target of $3.75 for the near short term. The highest target price given by the Brokerage Firm to the stock is $5 and the lowest target is $3 for the short term. Analysts expect the variance to be within $1.77 of the average price.


Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. The Companys Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Cervical and Corpectomy. In addition to its silicon nitride-based spinal fusion products, the Company markets a line of non-silicon nitride spinal fusion products, which allows it to provide surgeons and hospitals with a range of products.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.